- October 22, 2020
- Organized By:
Sponsored by the U.S. Food & Drug Administration (FDA)
RADM Richardae Araojo - Associate Commissioner for Minority Health, Director of the Office of Minority Health and Health Equity (OMHHE), Office of the Commissioner, U.S. Food and Drug Administration
Beverly Becenti-Pigman - Chairperson, Navajo Nation Human Research Review Board
Rea Blakey - Moderator, Oncology Center of Excellence Associate Director, External Outreach and Engagement
Dr. Ursa Brown-Glaberman MD - Associate Professor, Division of Hematology/Oncology, University of New Mexico Health Sciences
Priscilla Chewiwi - Breast Cancer Patient & Clinical Trial Participant
Vivian Craig – Navajo Breast Cancer Patient & Previous Clinical Trial Participant
Dr. Gayle Dine’Chacon, MD – Adjunct Professor & Founder, Center for Native American Health, University of New Mexico Health Sciences Center; Associate Physician, Division of Global Health Equity, Brigham & Women’s Hospital
Melanie Royce, MD - Medical Officer, CDER/OOD, Division of Oncology 1
Rachael Tracy, MPH - Research Director, National Institutional Review Board, Chair, Division of Planning, Evaluation, and Research, Office of Public Health Support, Indian Health Service
The public is invited, and registration is free for “Conversations on Cancer: Building Connections Toward Native American Clinical Trial Participation.” The Oncology Center of Excellence presents the next public panel discussion in the Conversations on Cancer series. Since October is recognized as National Breast Cancer Awareness Month, the intentionally inclusive panel discussion will address the intersection of Native American cancer clinical trial participation and breast cancer.
A free-of-charge webcast of this workshop will be provided. Registration for the webcast is required at the link above. The link for the webcast will be provided to all registered no less than 24 hours prior to the start of the workshop.
FDA plans to post archived webcasts after the meeting, however, in cases where the transmission was not successful, archived webcasts will not be available.
For additional information, please send an email to: OCE-Engagement@fda.hhs.gov